Stock listing
NASDAQ:BEAM Beam Therapeutics Inc. Stock
Home listing (NASDAQ) of Beam Therapeutics Inc.
Follow Beam Therapeutics Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:BEAM
$27.23 USD -1.61 (-5.6%)
Close on Oct 30, 2026
- Day range
- $26.43 – $28.80 USDOct 30, 2026
- Volume
- 1.50M sharesOct 30, 2026
- Market cap
- $2.81B USDAt the close on Oct 30, 2026 · price × 103.3M shares outstanding
- 52-week range
- $20.23 – $38.26 USDLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
- Traded on an average day
- $47.82M USDMedian day 1.58M shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:BEAM · Home | $27.23 USD | -1.61 (-5.6%) | 1,497,886 | $28.27 | $28.80 | $26.43 | $28.84 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · NASDAQ:BEAM · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $27.23 | -1.61 | -5.6% | $28.27 | $28.80 | $26.43 | 1,497,886 | |
| $28.84 | +0.06 | +0.2% | $28.72 | $29.76 | $28.40 | 1,995,700 | |
| $28.78 | +3.88 | +15.6% | $24.61 | $28.86 | $24.50 | 5,003,200 | |
| $24.90 | +1.11 | +4.7% | $23.73 | $25.09 | $23.39 | 2,750,600 | |
| $23.79 | -0.26 | -1.1% | $24.00 | $24.11 | $23.65 | 1,400,500 | |
| $24.05 | -0.51 | -2.1% | $24.00 | $24.14 | $23.24 | 1,596,100 | |
| $24.56 | -0.28 | -1.1% | $24.39 | $25.29 | $24.00 | 1,383,600 | |
| $24.84 | -0.09 | -0.4% | $24.83 | $25.20 | $24.50 | 1,167,700 | |
| $24.93 | +0.74 | +3.1% | $24.00 | $25.06 | $23.61 | 1,479,500 | |
| $24.19 | +0.72 | +3.1% | $23.89 | $24.38 | $23.50 | 1,316,500 | |
| $23.47 | -1.26 | -5.1% | $24.56 | $24.56 | $23.16 | 1,645,800 | |
| $24.73 | +1.08 | +4.6% | $23.51 | $24.98 | $23.20 | 1,779,900 | |
| $23.65 | -0.78 | -3.2% | $24.13 | $24.26 | $23.28 | 1,660,700 | |
| $24.43 | -0.70 | -2.8% | $24.88 | $24.93 | $24.08 | 1,667,900 | |
| $25.13 | -0.57 | -2.2% | $25.63 | $26.09 | $24.94 | 1,412,800 | |
| $25.70 | +1.10 | +4.5% | $24.72 | $26.23 | $24.55 | 1,800,200 | |
| $24.60 | -0.17 | -0.7% | $24.26 | $24.69 | $23.91 | 2,425,900 | |
| $24.77 | -0.46 | -1.8% | $24.64 | $25.37 | $24.45 | 2,342,400 | |
| $25.23 | -0.44 | -1.7% | $26.80 | $26.94 | $24.87 | 2,516,700 | |
| $25.67 | +1.17 | +4.8% | $24.48 | $26.04 | $23.83 | 1,999,200 | |
| $24.50 | +0.11 | +0.5% | $25.00 | $25.48 | $24.21 | 1,497,500 | |
| $24.39 | -0.06 | -0.2% | $24.24 | $24.98 | $23.96 | 1,693,300 | |
| $24.45 | -0.07 | -0.3% | $24.79 | $25.20 | $24.41 | 1,555,600 | |
| $24.52 | +0.29 | +1.2% | $23.88 | $24.76 | $23.88 | 1,637,100 | |
| $24.23 | -0.04 | -0.2% | $24.02 | $24.66 | $23.44 | 1,273,600 | |
| $24.27 | -0.39 | -1.6% | $24.97 | $24.97 | $23.75 | 1,217,900 | |
| $24.66 | +0.29 | +1.2% | $23.88 | $24.81 | $23.16 | 2,283,000 | |
| $24.37 | -1.56 | -6.0% | $25.75 | $26.24 | $24.22 | 1,896,000 | |
| $25.93 | +0.67 | +2.7% | $25.62 | $26.50 | $25.07 | 1,987,800 | |
| $25.26 | +0.31 | +1.2% | $25.45 | $25.66 | $24.83 | 1,701,300 | |
| $24.95 | +0.28 | +1.1% | $24.92 | $25.18 | $24.26 | 2,286,600 | |
| $24.67 | +1.57 | +6.8% | $24.28 | $25.50 | $24.05 | 2,424,400 | |
| $23.10 | -0.12 | -0.5% | $23.41 | $23.65 | $22.67 | 1,817,700 | |
| $23.22 | -0.90 | -3.7% | $23.82 | $23.84 | $22.86 | 2,584,100 | |
| $24.12 | +0.13 | +0.5% | $24.02 | $24.93 | $23.99 | 1,457,100 | |
| $23.99 | -0.38 | -1.6% | $24.64 | $24.76 | $23.95 | 1,193,700 | |
| $24.37 | -0.805 | -3.2% | $24.76 | $24.89 | $23.98 | 1,980,300 | |
| $25.18 | -1.655 | -6.2% | $26.70 | $26.70 | $25.11 | 2,842,800 | |
| $26.83 | -2.83 | -9.5% | $26.76 | $27.30 | $25.04 | 6,174,900 | |
| $29.66 | +0.20 | +0.7% | $28.91 | $29.97 | $28.91 | 1,181,600 | |
| $29.46 | +0.17 | +0.6% | $29.49 | $29.65 | $28.02 | 1,266,600 | |
| $29.29 | +0.27 | +0.9% | $29.27 | $30.18 | $28.23 | 1,292,200 | |
| $29.02 | -0.41 | -1.4% | $28.82 | $29.56 | $28.70 | 887,900 | |
| $29.43 | +0.11 | +0.4% | $28.82 | $29.82 | $28.33 | 1,308,000 | |
| $29.32 | -1.16 | -3.8% | $29.53 | $30.50 | $29.01 | 1,330,100 | |
| $30.48 | +0.29 | +1.0% | $30.14 | $30.82 | $29.72 | 1,268,800 | |
| $30.19 | -0.84 | -2.7% | $30.96 | $31.02 | $29.76 | 1,386,700 | |
| $31.03 | +2.70 | +9.5% | $28.94 | $31.48 | $28.78 | 2,188,665 | |
| $28.33 | -1.43 | -4.8% | $29.25 | $29.35 | $28.23 | 1,245,306 | |
| $29.76 | +1.37 | +4.8% | $28.74 | $30.50 | $28.61 | 2,457,300 | |
| $28.39 | -0.68 | -2.3% | $28.08 | $29.10 | $26.98 | 2,409,500 | |
| $29.07 | +2.50 | +9.4% | $28.41 | $29.16 | $27.64 | 3,111,300 | |
| $26.57 | -0.53 | -2.0% | $26.18 | $26.93 | $26.00 | 1,195,700 | |
| $27.10 | +0.35 | +1.3% | $26.52 | $27.24 | $26.40 | 1,470,200 | |
| $26.75 | +0.24 | +0.9% | $26.64 | $26.88 | $25.71 | 1,229,800 | |
| $26.51 | -0.20 | -0.7% | $27.26 | $27.49 | $26.26 | 2,021,800 | |
| $26.71 | -0.14 | -0.5% | $27.00 | $27.31 | $26.62 | 1,554,100 | |
| $26.85 | -0.43 | -1.6% | $27.45 | $27.57 | $26.53 | 1,329,400 | |
| $27.28 | -0.20 | -0.7% | $27.46 | $27.95 | $27.11 | 1,253,700 | |
| $27.48 | +0.23 | +0.8% | $27.71 | $28.35 | $27.13 | 1,324,200 | |
| $27.25 | +0.18 | +0.7% | $26.71 | $27.99 | $26.56 | 1,168,600 | |
| $27.07 | -1.28 | -4.5% | $28.42 | $28.47 | $26.62 | 2,056,900 | |
| $28.35 | +2.44 | +9.4% | $26.73 | $28.42 | $26.42 | 2,150,800 | |
| $25.91 | +0.39 | +1.5% | $25.55 | $26.25 | $24.67 | 1,295,000 | |
| $25.52 | -0.97 | -3.7% | $26.83 | $26.93 | $25.36 | 1,068,100 | |
| $26.49 | +0.47 | +1.8% | $26.03 | $26.52 | $25.37 | 1,454,000 |
- Ticker
- NASDAQ:BEAM
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Oct 27, 2026
Beam Therapeutics Reports Initial Clinical Data from Phase 1/2 Trial of BEAM-301, Demonstrating Proof of Concept for Genetic Correction in Glycogen Storage Disease Type Ia (GSDIa) at ESGCT 33rd Annual Congress
Latest earnings call · Feb 24, 2026
Beam Therapeutics (NASDAQ:BEAM) Q4 2025 Earnings Call
Replay and transcript
Latest deck · September 2026
European Respiratory Society (ERS) Congress 2026
Conference · 9 slides
Calls
Replays
Beam Therapeutics (NASDAQ:BEAM) Q4 2025 Earnings Call
Tue, Feb 24, 2026 · 8:00 AM ET
Watch TranscriptBeam Therapeutics (NASDAQ:BEAM) Q3 2024 Earnings Call
Tue, Nov 05, 2024 · 8:30 AM ET
Watch Transcript
Latest news
Beam Therapeutics Reports Initial Clinical Data from Phase 1/2 Trial of BEAM-301, Demonstrating Proof of Concept for Genetic Correction in Glycogen Storage Disease Type Ia (GSDIa) at ESGCT 33rd Annual Congress
Oct 27, 2026
Closed $24.90 (+4.7%) on Oct 27, 2026
Beam Therapeutics Presents Updated Clinical Data from the Phase 1/2 Trial of BEAM-302 in Alpha-1 Antitrypsin Deficiency (AATD) at the European Respiratory Society (ERS) Congress 2026
Sep 8, 2026
Closed $26.83 (-9.5%) on Sep 8, 2026
Beam Therapeutics Appoints Eric Foster as Chief Commercial Officer
Sep 1, 2026
Closed $29.02 (-1.4%) on Sep 1, 2026
Beam Therapeutics to Participate in Upcoming September 2026 Investor Conferences
Aug 31, 2026
Closed $29.43 (+0.4%) on Aug 31, 2026
Beam Therapeutics Reports Second Quarter 2026 Financial Results and Announces First Patient Dosed in Global Pivotal Cohort of BEAM-302 Trial in Alpha-1 Antitrypsin Deficiency (AATD)
Aug 4, 2026
Closed $28.35 (+9.4%) on Aug 4, 2026
Beam Therapeutics to Present Updated Data from Phase 1/2 Trial of BEAM-302 in Alpha-1 Antitrypsin Deficiency (AATD) in Late-Breaking Oral Presentation at the European Respiratory Society (ERS) Congress 2026
Jul 23, 2026
Closed $25.91 (-2.7%) on Jul 23, 2026
Beam Therapeutics Announces Clearance of Investigational New Drug Application for BEAM-304 for the Treatment of Phenylketonuria (PKU) by the United States (U.S.) Food and Drug Administration
Jun 18, 2026
Closed $34.14 (+5.1%) on Jun 18, 2026
Beam Therapeutics Presents Recently Reported Topline Clinical Data for BEAM-302 in Alpha-1 Antitrypsin Deficiency (AATD) at the American Thoracic Society (ATS) 2026 International Conference
May 18, 2026
Closed $26.33 (-1.8%) on May 19, 2026
Beam Therapeutics to Present at 2026 RBC Capital Markets Global Healthcare Conference
May 13, 2026
Closed $31.85 (+0.9%) on May 13, 2026
Decks
European Respiratory Society (ERS) Congress 2026
Conference · 9 slides · September 2026
ATS 2026
Conference · 21 slides · May 2026
FY 2025 Earnings Presentation
Earnings · 39 slides · Feb 24, 2026
Investor Presentation (January 2026)
Investor deck · 27 slides · Jan 12, 2026
Beam Therapeutics Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 23 in the last 12 months · 157 in all · newest Oct 27, 2026 · oldest 2020
- Calls
- 2 calls with a replay · 2 with a transcript · latest Feb 24, 2026
- Decks
- 14 decks · latest September 2026
Where Beam Therapeutics Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:BEAM · Home listing · This page | NASDAQ | United States | USD |
| BMV:BEAM | BMV | Mexico | MXN |
| BOATS:BEAM | BOATS | United States | USD |
| BIVA:BEAM | BIVA | Mexico | MXN |
Log in to ask 6ix AI your own questions about Beam Therapeutics Inc.